Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Antigen-specific therapy for autoimmune disease.

L C Harrison1, D A Hafler

  • 1Autoimmunity and Transplantation Division, The Walter and Eliza Hall Institute of Medical Research, Royal Melbourne Hospital, Parkville 3050, Australia. harrison@wehi.edu.au

Current Opinion in Immunology
|December 5, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Siglec-10 expression is up-regulated in activated human CD4<sup>+</sup> T cells.

Human immunology·2020
Same author

The Great Pretender: early syphilis mimicking acute sclerosing cholangitis.

Frontline gastroenterology·2017
Same author

Interferon-gamma released from omental adipose tissue of insulin-resistant humans alters adipocyte phenotype and impairs response to insulin and adiponectin release.

International journal of obesity (2005)·2017
Same author

A fatal case of transplantation-mediated alloimmune thrombocytopenia following liver transplantation.

Hematology (Amsterdam, Netherlands)·2016
Same author

GM3 ganglioside and phosphatidylethanolamine-containing lipids are adipose tissue markers of insulin resistance in obese women.

International journal of obesity (2005)·2015
Same author

Maturity-onset diabetes of the young type 5 in a family with diabetes and mild kidney disease diagnosed by whole exome sequencing.

Internal medicine journal·2014

Self-antigens show therapeutic potential in animal models of autoimmune disease by inducing tolerance. Mucosa-mediated antigen-specific therapy is promising but requires clinical validation in humans.

Area of Science:

  • Immunology
  • Autoimmune Diseases
  • Therapeutic Strategies

Background:

  • Autoimmune diseases involve the immune system attacking self-tissues.
  • Therapeutic approaches often aim to re-establish immune tolerance.
  • Animal models are crucial for validating novel treatment strategies.

Purpose of the Study:

  • To validate the therapeutic application of self-antigens in autoimmune disease models.
  • To elucidate mechanisms of antigen-induced tolerance.
  • To assess the potential of mucosa-mediated tolerance for human autoimmune diseases.

Main Methods:

  • Utilized inbred animal models of autoimmune disease.
  • Investigated mechanisms including apoptosis, anergy, regulatory T cells, and immune deviation.

Related Experiment Videos

  • Focused on antigen properties, delivery modes, and routes.

    • Main Results:

    • Self-antigen application demonstrated therapeutic validation in animal models.
    • Mechanisms of antigen-induced tolerance are being clarified.
    • Mucosa-mediated tolerance emerged as a predominant antigen-specific therapy mode.

    Conclusions:

    • Self-antigens are validated therapeutic tools in preclinical autoimmune disease studies.
    • Understanding tolerance mechanisms is key to optimizing antigen-specific therapies.
    • Clinical efficacy of mucosa-mediated tolerance in human autoimmune diseases remains to be demonstrated.